Trial intelligence / Profile preview

Growth and behavioral development of IVF-ET offspring after maternal kidney-tonifying Chinese medicine

ChiCTR2100055031Phase 4Recruiting

Sponsor
Sun Yat-sen Memorial Hospital
Start
Dec 2021
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in infertility comparing Zishen Yutai Pills maternal ART exposure with Placebo maternal ART exposure (2 arms). Primary endpoints: Gesell scale score at 66±3 months, Wechsler Intelligence Scale for Children score at 78±3 months and 5 more. Started Dec 2021; status: recruiting.

02

Drugs

Zishen Yutai Pill
03

Conditions

infertility

Beyond the preview

Go deeper on ChiCTR2100055031.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100055031.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call